{"title":"纳米颗粒和脂质体产品在印度和美国的监管观点概述","authors":"Rinshu Dabas, Pankaj Musyuni, Geeta Aggarwal","doi":"10.1177/17411343231206469","DOIUrl":null,"url":null,"abstract":"Nanoparticles and Liposomal products have significantly contributed for managing various disorders and diseases. Drug delivery system is important and assisting in developing various therapeutic regimen. The present write-up discussed the role of novel drug delivery system, particularly applications of nanoparticles and liposomal products and regulatory requirement for these products. The article emphasises that there are enormous research opportunities and global collaboration is essential for promoting research and drug approval.","PeriodicalId":91117,"journal":{"name":"Journal of generic medicines","volume":"14 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"An overview of regulatory perspectives of nanoparticles and liposomal products in India and USA\",\"authors\":\"Rinshu Dabas, Pankaj Musyuni, Geeta Aggarwal\",\"doi\":\"10.1177/17411343231206469\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Nanoparticles and Liposomal products have significantly contributed for managing various disorders and diseases. Drug delivery system is important and assisting in developing various therapeutic regimen. The present write-up discussed the role of novel drug delivery system, particularly applications of nanoparticles and liposomal products and regulatory requirement for these products. The article emphasises that there are enormous research opportunities and global collaboration is essential for promoting research and drug approval.\",\"PeriodicalId\":91117,\"journal\":{\"name\":\"Journal of generic medicines\",\"volume\":\"14 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-10-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of generic medicines\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/17411343231206469\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of generic medicines","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/17411343231206469","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
An overview of regulatory perspectives of nanoparticles and liposomal products in India and USA
Nanoparticles and Liposomal products have significantly contributed for managing various disorders and diseases. Drug delivery system is important and assisting in developing various therapeutic regimen. The present write-up discussed the role of novel drug delivery system, particularly applications of nanoparticles and liposomal products and regulatory requirement for these products. The article emphasises that there are enormous research opportunities and global collaboration is essential for promoting research and drug approval.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
